Remove 2004 Remove Hospitals Remove Packaging
article thumbnail

Pharmacy practice in emergency care: patient safeguarding

Hospital Pharmacy Europe

Given the pressures on inpatient care, notably bed capacity and blocking (bottlenecks in patients being able to leave the ED because of lack of capacity in the downstream system), moving pharmaceutical care closer to the hospital front door– that is, to the ED – is logical. ED pharmacy services were surveyed for the first time in 2004.

article thumbnail

Regulating decentralised manufacturing in the UK – a legal perspective

European Pharmaceutical Review

In the EU, the EU pharmaceutical package of reform 5 includes a proposed new Directive, 6 which will replace the current Medicines Directive (2001/83/EC). For example, clinicians and hospitals. Available from: [link] Human Medicines Regulations 2012 and Medicines for Human Use (Clinical Trials) Regulations 2004.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Why Are FDA Inspections So Ineffective and Disappointing?

The People's Pharmacy

“The FDA said Global Pharma failed to use adequate, tamper-evident packaging and distributed the drugs without proper preservatives.” drug supply and made their way to patients’ medicine cabinets, hospital supply closets and IV drips.” Since the start of 2013, pharmaceutical companies based in the U.S.

FDA 72
article thumbnail

Considerations for a Decentralized Manufacturing Paradigm

ISPE

4 , 5 Additionally, reducing shipping limitations—such as packaging, storage, and transportation durations—helps speed up patient access in certain instances while ensuring there is no negative impact to the product’s critical quality attributes (CQAs). September 2004. September 2004. 3 (2022):593–607. Guidance for Industry.